Total Payments
$18,996
2024 Payments
$5,286
Companies
34
Transactions
303
Medicare Patients
4,601
Medicare Billing
$453,316
Payment Breakdown by Category
Food & Beverage$8,789 (46.3%)
Travel$6,748 (35.5%)
Other$3,250 (17.1%)
Education$209.99 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,789 | 284 | 46.3% |
| Travel and Lodging | $6,748 | 17 | 35.5% |
| Grant | $3,250 | 1 | 17.1% |
| Education | $209.99 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $6,583 | 28 | $0 (2019) |
| CVRx, Inc. | $4,197 | 23 | $0 (2024) |
| ABIOMED | $2,031 | 7 | $0 (2024) |
| Abbott Laboratories | $709.40 | 12 | $0 (2024) |
| Boston Scientific Corporation | $669.10 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $654.20 | 32 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $622.59 | 26 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $486.77 | 25 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $313.16 | 14 | $0 (2024) |
| Novo Nordisk Inc | $300.11 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,286 | 76 | ABIOMED ($1,937) |
| 2023 | $3,886 | 79 | CVRx, Inc. ($2,291) |
| 2022 | $1,303 | 55 | Abbott Laboratories ($206.62) |
| 2021 | $739.72 | 41 | Actelion Pharmaceuticals US, Inc. ($138.23) |
| 2020 | $275.68 | 12 | Boston Scientific Corporation ($143.05) |
| 2019 | $4,197 | 10 | Medtronic Vascular, Inc. ($3,519) |
| 2018 | $358.87 | 6 | Abbott Laboratories ($178.55) |
| 2017 | $2,949 | 24 | Medtronic Vascular, Inc. ($2,949) |
All Payment Transactions
303 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $102.12 | General |
| Category: Cardiovascular Device | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $164.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Cardiology | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.01 | General |
| Category: Cardiovascular | ||||||
| 11/11/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $33.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/14/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $3.78 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.02 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/03/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/03/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $20.38 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.60 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $131.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $73.63 | General |
| Category: Cardiovascular Device | ||||||
| 08/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.50 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/23/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,602 | 2,054 | $547,469 | $137,158 |
| 2022 | 26 | 1,506 | 1,865 | $494,503 | $142,083 |
| 2021 | 21 | 1,078 | 1,373 | $437,054 | $129,603 |
| 2020 | 14 | 415 | 512 | $131,766 | $44,472 |
Total Patients
4,601
Total Services
5,804
Medicare Billing
$453,316
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 194 | 303 | $65,623 | $26,363 | 40.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 107 | 239 | $53,161 | $22,148 | 41.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 53 | 132 | $76,892 | $21,684 | 28.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 71 | 72 | $30,189 | $9,716 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 59 | $17,190 | $7,651 | 44.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 38 | 40 | $52,152 | $7,491 | 14.4% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 11 | 13 | $26,848 | $5,920 | 22.1% |
| 93456 | Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 25 | 26 | $35,796 | $5,812 | 16.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 109 | 114 | $32,246 | $5,781 | 17.9% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 20 | 20 | $34,112 | $5,470 | 16.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 32 | 32 | $13,314 | $4,960 | 37.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 463 | 511 | $25,550 | $3,111 | 12.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 26 | 27 | $6,039 | $2,397 | 39.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 17 | 17 | $21,772 | $2,199 | 10.1% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 18 | 20 | $8,320 | $1,464 | 17.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 100 | 129 | $2,451 | $1,084 | 44.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 13 | 13 | $11,260 | $825.64 | 7.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 69 | 74 | $11,544 | $716.86 | 6.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 19 | 19 | $1,535 | $568.29 | 37.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 47 | 54 | $3,882 | $556.92 | 14.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 14 | 19 | $2,395 | $308.48 | 12.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 24 | 26 | $1,976 | $260.52 | 13.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 24 | 26 | $8,554 | $212.19 | 2.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 16 | 16 | $816.00 | $173.28 | 21.2% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 17 | 18 | $1,953 | $162.00 | 8.3% |
About Dr. Vikram Raje, DO
Dr. Vikram Raje, DO is a Interventional Cardiology healthcare provider based in Gainesville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2011. The National Provider Identifier (NPI) number assigned to this provider is 1649563255.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikram Raje, DO has received a total of $18,996 in payments from pharmaceutical and medical device companies, with $5,286 received in 2024. These payments were reported across 303 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($8,789).
As a Medicare-enrolled provider, Raje has provided services to 4,601 Medicare beneficiaries, totaling 5,804 services with total Medicare billing of $453,316. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Advanced Heart Failure and Transplant Cardiology
- Location Gainesville, GA
- Active Since 05/16/2011
- Last Updated 12/07/2020
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1649563255
Products in Payments
- Resolute (Device) $4,951
- Barostim Neo System (Device) $4,197
- Impella (Device) $2,031
- LifeVest (Device) $622.59
- VERQUVO (Drug) $490.43
- CARDIOMEMS (Device) $341.68
- UPTRAVI (Drug) $304.57
- CAMZYOS (Drug) $276.75
- Optimizer (Device) $242.34
- Integrity (Device) $209.99
- CardioMEMS HF System (Device) $201.56
- ELIQUIS (Drug) $189.92
- OPSUMIT (Drug) $182.20
- XARELTO (Drug) $177.23
- Rybelsus (Drug) $161.56
- VENOVO (Device) $157.14
- JARDIANCE (Drug) $154.76
- FLOWTRIEVER CATHETER, S (Device) $141.94
- WINREVAIR (Biological) $138.14
- ENTRESTO (Drug) $136.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Gainesville
Dr. Arthur Lee, Md, MD
Interventional Cardiology — Payments: $2.1M
Interventional Cardiology $2.1M
Stephane Rinfret
Interventional Cardiology — Payments: $69,149
Interventional Cardiology $69,149
Dr. Christopher Caputo, Do, DO
Interventional Cardiology — Payments: $67,022
Interventional Cardiology $67,022
Zachary George, M.d, M.D
Interventional Cardiology — Payments: $60,629
Interventional Cardiology $60,629
Dr. Habib Samady, Md, MD
Interventional Cardiology — Payments: $43,588
Interventional Cardiology $43,588
Dr. Jeet Mehta, M.d, M.D
Interventional Cardiology — Payments: $25,361
Interventional Cardiology $25,361